Former Pfizer executive Erica Mann is set to join Bayer HealthCare LLC as the new president of its Consumer Care Division.


Bayer Consumer Care, Erica Mann, president, Consumer Care Division, Bayer HealthCare, Pfizer Nutritional Health, Wyeth, Jorg Reinhardt, OTC market






































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Bayer Consumer Care names president

February 24th, 2011

MORRISTOWN, N.J. – Former Pfizer executive Erica Mann is set to join Bayer HealthCare LLC as the new president of its Consumer Care Division.

Plans call for Mann, most recently president and general manager of Pfizer Nutritional Health, to start at Bayer on March 14. She also will become a member of the Bayer HealthCare executive committee, the company said.

According to Bayer, Mann was a member of the Pfizer senior management team and joined that company with its acquisition of Wyeth.

As senior vice president of nutrition at Wyeth, Mann helped establish the shape and strategic direction of the new nutrition business unit, and as managing director of Wyeth Australia & New Zealand she introduced a range of significant medicines and nutritionals. Mann also led Wyeth's pharmaceutical business in South Africa for over a decade as managing director and chief executive officer and was the first woman to serve as CEO of a pharmaceutical company in that country, Bayer said.

Earlier in her career, she held positions of increasing responsibility at Lederle Laboratories, Johnson & Johnson and Eli Lilly.

"Over the past 25 years, Ms. Mann has become noted in the industry for her strong record of delivering business results. Her outstanding experience and insights will drive [Bayer] Consumer Care to take advantage of the sustained growth forecast for the OTC market," stated Jorg Reinhardt, chairman of Bayer HealthCare AG and chairman of the Bayer HealthCare executive committee.

Advertisement